Specific disease-contributing cells

“Specific disease-contributing cells” is a broad term used to denote the distinct populations of cells within an organism that actively promote or sustain a disease process. These may be genetically altered cells (such as malignant cells in cancer), abnormally activated immune cells (in autoimmune and inflammatory diseases), or otherwise dysfunctional cells (e.g., degenerate neurons in neurodegeneration). Modern research uses genomics, single-cell technologies, and disease models to identify, characterize, and sometimes therapeutically target these specific cell populations for improved disease intervention. However, the term itself does not refer to a single molecular target and requires further specification to identify actual therapeutic targets (such as “CD20-positive B lymphocyte” or “HER2-positive epithelial cell”). This entry represents a broad conceptual category, not a specific molecule or receptor suitable for exact therapeutic targeting or data structuring. Further specification is required for actionable molecular target information.

Varies—may include induction of cell death, inhibition of proliferation, modification of immune response, or selective cell depletion, depending on cell type